Sodium Valproate Strandhaven 200 mg/5 ml Oral Solution

Manufacturer/MA Holder: Strandhaven Limited t/a Somex Pharma,
MA Number: PL 15764/0154

Important information

Please refer to the MHRA PREVENT Programme.

Drug Safety Category

2

Active Ingredient

Valproate (Sodium Valporate, Valproic Acid, Valproate Semisodium)

Formulation

Oral Solution

Strength

200mg/5ml (40mg/ml)

Licensed for use with feeding tube

No

Confirmed as carbohydrate free

No

Length/Diameter

Unknown

SPC URL

Open SPC

Excipients of concern

Sodium Propyl Parahydroxybenzoate (E217)0.41mg/ml
Sodium Methyl Parahydroxybenzoate (E219)0.85mg/ml
Sorbitol (E420)174mg/ml
Ponceau 4R (E124)0.5mg/ml
Sodium ContentUndisclosed